[ad_1]
May 21, 2021, Dublin (GLOBE NEWSWIRE)- “Cough Syrup Market by Product Type, Age Group and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027” Report has been added to ResearchAndMarkets.com provide.
The global cough syrup market value in 2019 was US$522.73 million, and it is expected to reach US$61.082.5 billion by 2027, with a compound annual growth rate of 2.8% from 2020 to 2027.
Cough is one of the most common symptoms, and patients need medical help from primary care doctors and pulmonologists. Cough is an important defensive reflex, which can enhance the clearance rate of respiratory secretions and particles, and protect the lower respiratory tract from foreign bodies. The treatment suppression of cough may be related to disease or symptoms. The potential benefits of treating cough early may include preventing the vicious cycle of coughing.
The growth of the global cough syrup market is mainly caused by respiratory diseases. In addition, the increase in the elderly population and huge air pollution have further promoted the growth of the market. However, the abuse of cough syrup and strict regulatory framework hinder the growth of the market. On the contrary, the high market potential of untapped emerging economies is expected to provide profitable growth opportunities for market growth.
The cough syrup market is segmented according to product type, age group, distribution channel and region. By product, the market is divided into expectorants, antitussives/antitussives and combination drugs. According to age groups, the cough syrup market is divided into children and adults. Through distribution channels, the market is divided into retail pharmacies, hospital pharmacies and online pharmacies. From a regional perspective, the markets in North America, Europe, Asia Pacific and LAMEA are analyzed.
Main benefits
- The report requires detailed quantitative analysis and current global cough syrup market trends from 2020 to 2027 to identify major opportunities and strategic assessments.
- The market forecast will be studied from 2020 to 2027.
- The market size and estimates are based on a comprehensive analysis of key developments in the industry.
- Qualitative analysis based on innovative products helps strategic business planning.
- The development strategies adopted by major market participants were solicited to understand the competition in the global cough syrup market.
Key topics covered:
Chapter 1: Introduction
1.1.Report description
1.2.Main interests of stakeholders
1.3.Main market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.initial research
1.4.3.Analysis tools and models
1.4.4.initial research
Chapter 2: Executive Summary
2.1.The main findings of the research
2.2. Cxo perspective
Chapter 3: Market Overview
3.1.Market definition and scope
3.2.Main findings
3.2.1.Top investment pockets
3.2.2. 2019 best player rankings
3.3.Porter’s Five Forces Analysis
3.4.Market dynamics
3.4.1.Rider
3.4.1.1.Increase in the number of patients suffering from respiratory diseases
3.4.1.2.Advances in cough syrup products
3.4.1.3.The increase in the elderly population
3.4.2.Restraint
3.4.2.1.Cough Syrup Abuse
3.4.2.2.Strict regulations in developed countries
3.4.3.opportunity
3.4.3.1.Emerging Markets
3.5. COVID-19 cough syrup market impact analysis
Chapter 4: Cough Syrup Market, Divided by Product Type
Chapter 5: Cough Syrup Market by Age Group
Chapter 6: Cough Syrup Market, Divided by Distribution Channel
Chapter 7: Cough Syrup Market by Region
Chapter 8: Company Profile
8.1.Abbott Laboratories
8.1.1.Company Profile
8.1.2.Company snapshot
8.1.3.Operating business segment
8.1.4.product description
8.1.5.Operating results
8.1.6.Key strategic initiatives and development
8.2. Acella Pharmaceuticals, LLC
8.2.1.Company Profile
8.2.2.Company snapshot
8.2.3.Operating business segment
8.2.4.product description
8.3.GlaxoSmithKline
8.3.1.Company Profile
8.3.2.Company snapshot
8.3.3.Operating business segment
8.3.4.product description
8.3.5.Operating results
8.4.Johnson & Johnson Service
8.4.1.Company Profile
8.4.2.Company snapshot
8.4.3.Operating business segment
8.4.4.product description
8.4.5.Operating results
8.5.Merck Group
8.5.1.Company Profile
8.5.2.Company snapshot
8.5.3.Operating business segment
8.5.4.product description
8.5.5.Operating results
8.5.6.Key strategic initiatives and development
8.6.Novartis International
8.6.1.Company Profile
8.6.2.Company snapshot
8.6.3.Operating business segment
8.6.4.product description
8.6.5.Operating results
8.7.Pfizer
8.7.1.Company Profile
8.7.2.Company snapshot
8.7.3.Operating business segment
8.7.4.product description
8.7.5.Operating results
8.7.6.Key strategic initiatives and development
8.8.Procter
8.8.1.Company Profile
8.8.2.Company snapshot
8.8.3.Operating business segment
8.8.4.product description
8.8.5.Operating results
8.9. Reckitt Benckiser Group plc.
8.9.1.Company Profile
8.9.2.Company snapshot
8.9.3.Operating business segment
8.9.4.product description
8.9.5.Operating results
8.10.Sanofi
8.10.1.Company Profile
8.10.2.Company snapshot
8.10.3.Operating business segment
8.10.4.product description
8.10.5.Operating results
8.10.6.Key strategic initiatives and development
For more information about this report, please visit https://www.researchandmarkets.com/r/xcuqso
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
[ad_2]
Source link
